Star Lake BioscienceZhaoqing Guangdong Croissance future

Future contrôle des critères 1/6

Star Lake BioscienceZhaoqing Guangdong devrait augmenter ses bénéfices et son chiffre d'affaires de 18.1% et de 3.1% par an respectivement. Le BPA devrait croître de de 18.1% par an. Le rendement des capitaux propres devrait être 14.4% dans 3 ans.

Informations clés

18.1%

Taux de croissance des bénéfices

18.1%

Taux de croissance du BPA

Food croissance des bénéfices	22.2%
Taux de croissance des recettes	3.1%
Rendement futur des capitaux propres	14.4%
Couverture par les analystes	Low
Dernière mise à jour	30 Oct 2024

Mises à jour récentes de la croissance future

Recent updates

Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem

Nov 04

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly

Oct 27

Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings

Sep 25

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Jul 26

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

May 28

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

Apr 29

Prévisions de croissance des bénéfices et des revenus

SHSE:600866 - Estimations futures des analystes et données financières antérieures (CNY Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2026	18,479	1,356	N/A	3,210	2
12/31/2025	17,823	1,197	N/A	1,380	2
12/31/2024	17,062	1,026	N/A	2,416	2
9/30/2024	17,435	866	1,647	2,173	N/A
6/30/2024	17,594	954	1,593	2,009	N/A
3/31/2024	17,410	809	2,150	2,512	N/A
12/31/2023	17,374	678	1,650	2,026	N/A
9/30/2023	17,343	598	1,231	1,503	N/A
6/30/2023	16,932	429	1,345	1,680	N/A
3/31/2023	17,479	546	445	845	N/A
12/31/2022	17,486	608	1,210	1,663	N/A
9/30/2022	16,084	595	1,493	2,009	N/A
6/30/2022	12,294	497	181	630	N/A
3/31/2022	7,938	301	-78	312	N/A
12/31/2021	4,071	152	-182	168	N/A
9/30/2021	1,170	96	-38	171	N/A
6/30/2021	1,129	130	-123	142	N/A
3/31/2021	1,134	151	-114	210	N/A
12/31/2020	1,116	149	-40	250	N/A
9/30/2020	1,011	137	-150	159	N/A
6/30/2020	1,081	156	-104	171	N/A
3/31/2020	1,038	145	2	183	N/A
12/31/2019	1,050	150	56	213	N/A
9/30/2019	1,061	132	136	226	N/A
6/30/2019	969	103	150	181	N/A
3/31/2019	926	71	75	104	N/A
12/31/2018	859	42	17	51	N/A
9/30/2018	849	-82	-23	16	N/A
6/30/2018	852	-101	N/A	28	N/A
3/31/2018	805	-124	N/A	72	N/A
12/31/2017	687	-158	N/A	50	N/A
9/30/2017	668	-35	N/A	52	N/A
6/30/2017	634	1	N/A	34	N/A
3/31/2017	638	22	N/A	28	N/A
12/31/2016	680	24	N/A	41	N/A
9/30/2016	618	-232	N/A	11	N/A
6/30/2016	621	-333	N/A	2	N/A
3/31/2016	656	-397	N/A	-11	N/A
12/31/2015	730	-422	N/A	3	N/A
9/30/2015	882	-312	N/A	60	N/A
6/30/2015	923	-319	N/A	89	N/A
3/31/2015	912	-353	N/A	53	N/A
12/31/2014	871	-361	N/A	-20	N/A
9/30/2014	819	-163	N/A	-57	N/A
6/30/2014	817	-77	N/A	-58	N/A
3/31/2014	856	19	N/A	-81	N/A
12/31/2013	903	20	N/A	-28	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 600866 ( 18.1% par an) est supérieure au taux d'épargne ( 2.8% ).

Bénéfices vs marché: Les bénéfices de 600866 ( 18.1% par an) devraient croître plus lentement que le marché CN ( 26.2% par an).

Croissance élevée des bénéfices: Les bénéfices de 600866 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 600866 ( 3.1% par an) devrait croître plus lentement que le marché de CN ( 13.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 600866 ( 3.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 600866 devrait être faible dans 3 ans ( 14.4 %).

Star Lake BioscienceZhaoqing Guangdong Croissance future

Future contrôle des critères 1/6

Informations clés

Mises à jour récentes de la croissance future

Price target increased by 11% to CN¥8.22

Recent updates

Why Star Lake BioscienceZhaoqing Guangdong's (SHSE:600866) Earnings Are Better Than They Seem

Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.16 in 3Q 2023)

Price target increased by 11% to CN¥8.22

Investor sentiment improves as stock rises 16%

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Seems To Use Debt Quite Sensibly

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 18%

Little Excitement Around Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Earnings

Star Lake BioscienceZhaoqing Guangdong (SHSE:600866) Ticks All The Boxes When It Comes To Earnings Growth

Now 20% undervalued

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2024 Results on Aug 27, 2024

Estimating The Intrinsic Value Of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHSE:600866)

New minor risk - Share price stability

Now 23% overvalued after recent price rise

Investor sentiment improves as stock rises 28%

There's No Escaping Star Lake Bioscience Co., Inc.Zhaoqing Guangdong's (SHSE:600866) Muted Earnings Despite A 26% Share Price Rise

New minor risk - Financial position

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.073 in 1Q 2023)

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Annual General Meeting, May 13, 2024

Investor sentiment improves as stock rises 25%

Now 21% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q1, 2024 Results on Apr 23, 2024

Now 21% undervalued after recent price drop

Now 23% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Now 23% undervalued after recent price drop

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Fiscal Year 2023 Results on Apr 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.053 in 3Q 2022)

New minor risk - Profit margin trend

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2023 Results on Aug 29, 2023

Full year 2022 earnings released: EPS: CN¥0.51 (vs CN¥0.14 in FY 2021)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.053 (vs CN¥0.005 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.075 (vs CN¥0.056 in 2Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.005 (vs CN¥0.035 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.056 (vs CN¥0.07 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.047 (vs CN¥0.044 in 1Q 2020)

New 90-day low: CN¥3.77

New 90-day low: CN¥4.39

New 90-day high: CN¥4.95

New 90-day low: CN¥4.42

Third quarter earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high - CN¥5.57

First half earnings released

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong to Report First Half, 2020 Results on Aug 25, 2020

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance